Date Initiated by Firm |
October 27, 2020 |
Create Date |
December 10, 2020 |
Recall Status1 |
Terminated 3 on August 11, 2021 |
Recall Number |
Z-0558-2021 |
Recall Event ID |
86873 |
Product Classification |
Cannula, trocar, ophthalmic - Product Code NGY
|
Product |
MANI Infusion Cannula 23G S - Product Usage: for use in injecting perfusate or aspirating out intraocular materials during ophthalmic surgery Ref: MTC 23S |
Code Information |
Lot Codes: V180082900, Exp. Date: 2020/11 and V190000100, Exp Date: 2020/12 |
Recalling Firm/ Manufacturer |
Mani, Inc. - Kiyohara Facility Park 8-3 Kiyoharakogyodanchi; Kiyoharakogyodanchi; Kiyoharakogyodanchi Utsunomiya Japan
|
Manufacturer Reason for Recall |
Dimensions of the Luer connector parts out of specification, may cause leakage of fluid and unintended disconnection during use
|
FDA Determined Cause 2 |
Unknown/Undetermined by firm |
Action |
MANI Inc. issued Voluntary Removal letter issued on 10/27/20 via email to the US Distributor stating reason for removal, health risk and action to take: request distributors to return the devices. If there are MANI TROCAR KIT and MANI INFUSION CANNULA in your stock and/or your customer's stock: Please write the returning Q'ty. in the list ,"Returned" If MANI TROCAR KIT and MANI INFUSION CANNULA are already used up : Please write the used Q'ty. in the list , "Used.
Please send this sheet and relevant items if you have to our address below.
Any costs/fees related to this return shipment should be charged to MANI FedEx account.
MANI, INC.
8-3, Kiyohara Industrial Park, Utsunomiya, Tochigi, 321-3231, Japan |
Quantity in Commerce |
60 units (US) |
Distribution |
US Nationwide distribution in the state of MO. |
Total Product Life Cycle |
TPLC Device Report
|
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|